Abstract P5-01-04: Correlation of HER2 receptor expression and in vivo activity of the HER2-targeting therapies trastuzumab deruxtecan (DS-8201a) and T-DM1 activity in a panel of b... von Simonson, Alyssa, Forofontov, Peter, Flores, Johnnie R, Hernandez, Kimberly, Cabang, April, Lang, Amy, Rodriguez, Gladys, Papadopoulos, Kyriakos, Beeram, Murali, Rosenthal, Arthur, DeBerry, Brittany, Smith, Lon, Drengler, Ronald, Patnaik, Amita, Rasco, Drew, Rodriguez, Luis, Abbate, Steven, Ulmer, Scott, Wick, Michael

Volltext

Abstract P1-13-03: Establishment and characterization of two T-DM1-resistant, ER+/HER2+ breast XPDX models developed sequentially from the same patient with differential in vivo se... von Plasko, George, Flores, Johnnie, Simonson, Alyssa, Forofontov, Peter, Varma, Ashwin, Lang, Amy, Rodriguez, Gladys, Papadopoulos, Kyriakos P., Rasco, Drew, Patnaik, Amita, Conway, Bruce, Johnston, Joe, Wick, Michael

Volltext

Abstract 412: Correlation of drug sensitivity to clinical response in XPDX models established from patients treated with KRAS-G12C-inhibitor therapy von Flores, Johnnie, Simonson, Alyssa, Forofontov, Peter, Stackpole, Anna, Rasco, Drew, Patnaik, Amita, Papadopoulos, Kyriakos, DesRochers, Teresa, Williams, Natalie, Drengler, Ronald, Smith, Lon, Wick, Michael J.

Volltext